Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
---|---|---|---|---|
MDA-MB-231 | GSK2334470 | 10.0 | 0.7810 | -0.00052 |
MDA-MB-231 | Ribociclib | 0.001 | 0.8001 | 0.00393 |
MDA-MB-231 | Ribociclib | 0.001 | 0.8125 | -0.00031 |
MDA-MB-231 | Ribociclib | 0.001 | 0.7806 | 0.00092 |
MDA-MB-231 | Ribociclib | 0.003162278 | 0.8113 | -0.00305 |
MDA-MB-231 | Ribociclib | 0.003162278 | 0.8105 | 0.00066 |
MDA-MB-231 | Ribociclib | 0.003162278 | 0.8385 | -0.00156 |
MDA-MB-231 | Ribociclib | 0.01 | 0.7433 | -0.00087 |
MDA-MB-231 | Ribociclib | 0.01 | 0.6856 | -0.00405 |
MDA-MB-231 | Ribociclib | 0.01 | 0.7381 | 0.00201 |
MDA-MB-231 | Ribociclib | 0.031622777 | 0.7537 | -0.00061 |
MDA-MB-231 | Ribociclib | 0.031622777 | 0.7297 | -0.00030 |
MDA-MB-231 | Ribociclib | 0.031622777 | 0.7531 | 0.00137 |
MDA-MB-231 | Ribociclib | 0.1 | 0.6966 | -0.00001 |
MDA-MB-231 | Ribociclib | 0.1 | 0.5773 | 0.01430 |
MDA-MB-231 | Ribociclib | 0.1 | 0.6626 | 0.00909 |
MDA-MB-231 | Ribociclib | 0.316227766 | 0.6168 | 0.01085 |
MDA-MB-231 | Ribociclib | 0.316227766 | 0.5060 | 0.00807 |
MDA-MB-231 | Ribociclib | 0.316227766 | 0.6095 | 0.00618 |
MDA-MB-231 | Ribociclib | 1.0 | 0.5501 | 0.00450 |
MDA-MB-231 | Ribociclib | 1.0 | 0.5339 | 0.00210 |
MDA-MB-231 | Ribociclib | 1.0 | 0.5885 | 0.00781 |
MDA-MB-231 | Ribociclib | 3.16227766 | 0.4623 | 0.01165 |
MDA-MB-231 | Ribociclib | 3.16227766 | 0.4704 | 0.00559 |
MDA-MB-231 | Ribociclib | 3.16227766 | 0.4548 | 0.00213 |